SRF to set up Pharma Intermediates Plant at Dahej

The Board of Directors of SRF Limited at its meeting held on January 25, 2022 has approved project to create Pharma Intermediates Plant for undertaking precursor processes for production of Pharma products at Dahej at a cost of Rs. 190 Crores.

The new project is setup to tap new and upcoming business opportunities in the pharma space. The funds for this project will be raised through a mix of debt and internal accruals.

The proposed capacity is expected to be added by 30th November, 2022.

Shares of SRF Limited was last trading in BSE at Rs. 2467.70 as compared to the previous close of Rs. 2369.30. The total number of shares traded during the day was 71634 in over 8658 trades.

The stock hit an intraday high of Rs. 2524.40 and intraday low of 2293.00. The net turnover during the day was Rs. 173334000.00.

Source : Equity Bulls

Keywords

SRF INE647A01010 PharmaIntermediatesPlant Dahej ExpansionProject